Your session is about to expire
← Back to Search
Omega-3 Supplements for Cardiovascular Disease (FAS Trial)
FAS Trial Summary
This trial looks at the effects of a type of fish oil on metabolic risk factors, and whether individual genetic variation affects those results.
FAS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFAS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FAS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am on medication for high cholesterol, high blood pressure, diabetes, or I take blood thinners or omega-3 supplements.I am between 18 and 50 years old and healthy.My BMI is between 25 and 40.I do not have diabetes, high blood pressure, severe cholesterol issues, or heart disease.
- Group 1: capsules omega-3
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new participants being added to this experiment?
"According to clinicaltrials.gov, this investigation is not currently accepting participants despite having been posted on October 1st 2009 and last modified in September 6th 2022. Fortunately, 427 other investigations are actively recruiting patients right now."
Is this clinical experiment open to those aged 65 or older?
"The age range for this medical trial is 18 to 50, as indicated by the participating requirements."
What are the criteria for eligible enrolment in this clinical trial?
"To gain acceptance into this medical trial, prospective participants must have a cardiovascular illness and be between 18-50 years of age. 200 patients need to take part in the study overall."
Share this study with friends
Copy Link
Messenger